|
(MoneyNewsWire.Net, November 02, 2017 ) Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma. These regenerative medicines restore normal functions of cells & tissues. These medicines are available in different types such as genes, somatic cells, stem cells, and other types. Some of these medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the original structure of cells or tissues or organs. Regenerative medicines are used in varied range of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology, and orthopedic, among others. Majority of the researchers aim to focus on the development of innovative technologies to provide better regenerative medicines and effective healthcare treatment solutions to patients.
View Full Report @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-regenerative-medicines-market-275/
Increasing demand for improved healthcare solutions, rising funding from public & private organizations for the development of advanced healthcare solutions, and government initiatives to promote the development of regenerative medicine products are driving the growth of regenerative medicines market in the Middle East and Africa. However, inadequate number of healthcare professionals, insufficient healthcare infrastructure, and low adoption of regenerative medicine products due to poor economic status are some of the factors restraining the growth of regenerative medicines market in the Middle East and Africa.
Middle East and Africa regenerative medicines market is segmented based on product, therapy, and application. Based on product, the market is further sub-segmented as cell-based products and acellular products. Of these, cell-based products segment is estimated to account for larger share of Middle East and Africa regenerative medicines market by product in 2016. Further, Cell-based products segment is classified as autologous and allogeneic products. Based on therapy, the market is segmented as cell therapy, gene therapy, tissue engineering, and immunotherapy. Of these, cell therapy is estimated to command the highest share of the Middle East and Africa regenerative medicines market by therapy in 2016.
Based on application, the market is segmented as orthopedic & musculoskeletal spine, dermatology, central nervous system, cardiovascular, oncology, diabetes, and other applications. Among these, orthopedic & musculoskeletal spine is estimated to command the largest share of the Middle East and Africa regenerative medicines market by application in 2016.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-regenerative-medicines-market-275/request-sample
On the basis of geographical areas, Middle East and Africa regenerative medicines market is segmented as Middle East and South Africa.
The key players in regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).
Market Segmentation
1) Introduction
2) Product
Introduction
Cell-Based Products
Autologous Cell-Based Products
Allogeneic Cell-Based Products
Acellular Products
3) Therapy
Introduction
Cell Therapy
Gene Therapy
Tissue Engineering
Immunotherapy
4) Application
Introduction
Orthopedic & Musculoskeletal Spine
Dermatology
Cardiovascular
Central Nervous System
Oncology
Diabetes
Other Applications
Inquire before Buying @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-regenerative-medicines-market-275/inquire
Reasons to buy Middle East and Africa Regenerative Medicines Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of Product, Therapy and Application along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
